The effect of calcium channel blocker lercanidipine on low-grade inflammation parameters in essential hypertension patients

Harefuah

Volumn 145, Issue 12 SPEC. ISS., 2006, Pages 895-899

  Shurtz Swirski, Revital ^a   Farah, Raymond ^a   Sela, Shifra ^a,b   Shapiro, Galina ^a   Klempef, Regina ^a   Snitkovski, Tamara ^a   Kristal, Batya ^a,b  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Essential hypertension; Lercanidipine; Primed polymorphonuclear leukocytes; Vasodip

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; LERCANIDIPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; HUMAN; HYPERTENSION; INFLAMMATION; MIDDLE AGED; NEUTROPHIL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; HUMANS; HYPERTENSION; INFLAMMATION; MIDDLE AGED; NEUTROPHILS;

EID: 33947533381     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Burt VL, Cutler JA, Higgins M & al, Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension, 1995; 26: 60-69.
2. Mosterd A, D'Agostino RB, Silbershatz H & al, Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med, 1999; 340: 1221-1227.
3. Alexander RW, Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: A new perspective. Hypertension, 1995; 25: 155-161.
4. Swislocki ALM, Hoffman BB & Reaven GM, Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens, 1989; 2: 419-423.
5. Kristal B, Shurtz-Swirski R, Chezar J & al, Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. Am J Hypertens, 1998; 11: 921-928.
6. Sela S, Shurtz-Swirski R, Farah R & al, A link between polymorphonuclear leukocyte intracellular calcium, plasma insulin, and essential hypertension. Am J Hypertens, 2002; 15: 291-295.
7. Weiss SJ, Tissue destruction by neutrophils. N Engl J Med, 1989; 320: 365-376.
8. Sela S, Shurtz-Swirski R, Cohen-Mazor M & al, The primed peripheral polymorphonuclear leukocyte - a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol, 2005; 16: 2431-2438.
9. Shurtz-Swirski R, Sela S, Herskovits AT & al, Involvement of polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetes. Diabetes Care, 2001; 24: 104-110.
10. Sela S, Shurtz-Swirski R, Awad J & al, The involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in cigarette smokers. IMAJ, 2002; 4: 1015-1019.
11. Jacobi J, Sela S, Cohen HI & al, Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury. Am J Physiol Heart Circ Physiol, 2006; 290: H2051-2058.
12. Hernandez RH, Armas-Hernandez MJ, Velasco M & al, Calcium antagonists and atherosclerosis protection in hypertension. Am J Ther, 2003; 10: 409-414.
13. Bang LM, Chapman TM & Goa KL, Lercanidipine. A review of its efficacy in the management of hypertension. Drugs, 2003; 63: 2449-2472.
14. Sarafidis PA & Ruilope LM, Insulin Resistance, Hyperinsuline-mia, and Renal Injury: mechanisms and Implications. Am J Nephrol, 2006; 26: 232-244.
15. Kuypers FA, Lewis RA, Hua M & al, Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled Annexin V. Blood, 1996; 87: 1179-1187.
16. Pifer TB, McCullough KP, Port FK & al, Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int, 2002; 62: 2238-2245.
17. Koenig W, Sund M, Frohlich M & al, C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation, 1999; 99: 237-242.
18. Yasunari K, Maeda K, Nakamura M & Yoshikawa J, Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension, 2002; 39: 777-780.
19. Kosegawa I, Inaba M, Morita T & al, Effect of the vasodilatory beta-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension. Clin Exp Hypertens, 1998; 20: 751-761.
20. Jacobi J, Kristal B, Chezar J & al, Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med, 2005; 39: 1238-1248.